Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Herman Goossens

Showing results (411-420 of 485) with videos related to

Pageof 49
Sort By:
The Lancet. Infectious Diseases|November 5, 2015
Ebola: Europe-Africa research collaborationsPeter William Horby, Hubert Endzt, Hubert Endtz, et al.
BMC Infectious Diseases|January 24, 2024
Cross-border differences in the prevalence and risk factors for carriage of antimicrobial resistance in children attending daycare centers: a point prevalence study in the Netherlands and BelgiumSara Dequeker, Mitch van Hensbergen, Casper D J den Heijer, et al.
Antibiotics (Basel, Switzerland)|March 29, 2023
Disease-Specific Quality Indicators for Outpatient Antibiotic Prescribing for Respiratory Infections (ESAC Quality Indicators) Applied to Point Prevalence Audit Surveys in General Practices in 13 European CountriesAkke Vellinga, Addiena Luke-Currier, Nathaly Garzón-Orjuela, et al.
Scientific Reports|August 22, 2022
Profiling of humoral immune responses to norovirus in children across EuropeNele Villabruna, Ray W Izquierdo-Lara, Claudia M E Schapendonk, et al.
The European Journal of General Practice|May 30, 2023
The experiences of patients ill with COVID-19-like symptoms and the role of testing for SARS-CoV-2 in supporting them: A qualitative study in eight European countries during the first wave of the pandemicMelanie E Hoste, Marta Wanat, Nina Gobat, et al.
Stem Cells (Dayton, Ohio)|March 19, 2016
In Vivo Interleukin-13-Primed Macrophages Contribute to Reduced Alloantigen-Specific T Cell Activation and Prolong Immunological Survival of Allogeneic Mesenchymal Stem Cell ImplantsChloé J Hoornaert, Evi Luyckx, Kristien Reekmans, et al.
Frontiers in Medicine|September 27, 2021
Supporting Primary Care Professionals to Stay in Work During the COVID-19 Pandemic: Views on Personal Risk and Access to Testing During the First Wave of Pandemic in EuropeMarta Wanat, Melanie Hoste, Nina Gobat, et al.
Glia|September 30, 2016
Interleukin-13 immune gene therapy prevents CNS inflammation and demyelination via alternative activation of microglia and macrophagesCaroline Guglielmetti, Debbie Le Blon, Eva Santermans, et al.
The Journal of Antimicrobial Chemotherapy|April 22, 2022
Susceptibility profiles and resistance genomics of Pseudomonas aeruginosa isolates from European ICUs participating in the ASPIRE-ICU trialGabriel Torrens, Thomas Ewout van der Schalk, Sara Cortes-Lara, et al.
The Lancet. Infectious Diseases|December 26, 2012
Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trialPaul Little, Beth Stuart, Michael Moore, et al.
Pageof 49

Showing results (411-420 of 485) with videos related to

Sort By:
Pageof 49
The Lancet. Infectious Diseases|November 5, 2015
Ebola: Europe-Africa research collaborationsPeter William Horby, Hubert Endzt, Hubert Endtz, et al.
BMC Infectious Diseases|January 24, 2024
Cross-border differences in the prevalence and risk factors for carriage of antimicrobial resistance in children attending daycare centers: a point prevalence study in the Netherlands and BelgiumSara Dequeker, Mitch van Hensbergen, Casper D J den Heijer, et al.
Antibiotics (Basel, Switzerland)|March 29, 2023
Disease-Specific Quality Indicators for Outpatient Antibiotic Prescribing for Respiratory Infections (ESAC Quality Indicators) Applied to Point Prevalence Audit Surveys in General Practices in 13 European CountriesAkke Vellinga, Addiena Luke-Currier, Nathaly Garzón-Orjuela, et al.
Scientific Reports|August 22, 2022
Profiling of humoral immune responses to norovirus in children across EuropeNele Villabruna, Ray W Izquierdo-Lara, Claudia M E Schapendonk, et al.
The European Journal of General Practice|May 30, 2023
The experiences of patients ill with COVID-19-like symptoms and the role of testing for SARS-CoV-2 in supporting them: A qualitative study in eight European countries during the first wave of the pandemicMelanie E Hoste, Marta Wanat, Nina Gobat, et al.
Stem Cells (Dayton, Ohio)|March 19, 2016
In Vivo Interleukin-13-Primed Macrophages Contribute to Reduced Alloantigen-Specific T Cell Activation and Prolong Immunological Survival of Allogeneic Mesenchymal Stem Cell ImplantsChloé J Hoornaert, Evi Luyckx, Kristien Reekmans, et al.
Frontiers in Medicine|September 27, 2021
Supporting Primary Care Professionals to Stay in Work During the COVID-19 Pandemic: Views on Personal Risk and Access to Testing During the First Wave of Pandemic in EuropeMarta Wanat, Melanie Hoste, Nina Gobat, et al.
Glia|September 30, 2016
Interleukin-13 immune gene therapy prevents CNS inflammation and demyelination via alternative activation of microglia and macrophagesCaroline Guglielmetti, Debbie Le Blon, Eva Santermans, et al.
The Journal of Antimicrobial Chemotherapy|April 22, 2022
Susceptibility profiles and resistance genomics of Pseudomonas aeruginosa isolates from European ICUs participating in the ASPIRE-ICU trialGabriel Torrens, Thomas Ewout van der Schalk, Sara Cortes-Lara, et al.
The Lancet. Infectious Diseases|December 26, 2012
Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trialPaul Little, Beth Stuart, Michael Moore, et al.
Pageof 49